SAGE THERAPEUTICS INC's ticker is and the CUSIP is 78667J908. A total of 6 filers reported holding SAGE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,360,526 | +464.1% | 114,700 | +1188.8% | 0.01% | +700.0% |
| Q2 2023 | $418,478 | -16.9% | 8,900 | -25.8% | 0.00% | -50.0% |
| Q1 2023 | $503,520 | -64.1% | 12,000 | -67.4% | 0.00% | -33.3% |
| Q4 2022 | $1,403,552 | -9.0% | 36,800 | -6.6% | 0.00% | 0.0% |
| Q3 2022 | $1,543,000 | +3.4% | 39,400 | -14.7% | 0.00% | +50.0% |
| Q2 2022 | $1,492,000 | -9.7% | 46,200 | -7.4% | 0.00% | 0.0% |
| Q1 2022 | $1,652,000 | +235.1% | 49,900 | +330.2% | 0.00% | – |
| Q4 2021 | $493,000 | -60.0% | 11,600 | -58.3% | 0.00% | -100.0% |
| Q3 2021 | $1,232,000 | -63.5% | 27,800 | -53.2% | 0.00% | -75.0% |
| Q2 2021 | $3,375,000 | +244.0% | 59,400 | +353.4% | 0.00% | +300.0% |
| Q1 2021 | $981,000 | -83.0% | 13,100 | -80.4% | 0.00% | -90.0% |
| Q4 2020 | $5,770,000 | +139.0% | 66,700 | +68.9% | 0.01% | +25.0% |
| Q3 2020 | $2,414,000 | +251.9% | 39,500 | +139.4% | 0.01% | +166.7% |
| Q2 2020 | $686,000 | +48.5% | 16,500 | +2.5% | 0.00% | -25.0% |
| Q1 2020 | $462,000 | -97.7% | 16,100 | -94.3% | 0.00% | -97.1% |
| Q4 2019 | $20,264,000 | +117.9% | 280,700 | +323.4% | 0.14% | +84.0% |
| Q3 2019 | $9,301,000 | -15.2% | 66,300 | +10.7% | 0.08% | -24.2% |
| Q2 2019 | $10,967,000 | -5.4% | 59,900 | -17.8% | 0.10% | -23.3% |
| Q1 2019 | $11,595,000 | +106.6% | 72,900 | +24.4% | 0.13% | +163.3% |
| Q4 2018 | $5,613,000 | -1.9% | 58,600 | +44.7% | 0.05% | +8.9% |
| Q3 2018 | $5,721,000 | +23.1% | 40,500 | +36.4% | 0.04% | +12.5% |
| Q2 2018 | $4,649,000 | -7.2% | 29,700 | -4.5% | 0.04% | -20.0% |
| Q1 2018 | $5,009,000 | -69.3% | 31,100 | -68.6% | 0.05% | -56.5% |
| Q4 2017 | $16,323,000 | +410.7% | 99,100 | +93.2% | 0.12% | +296.6% |
| Q3 2017 | $3,196,000 | +252.0% | 51,300 | +350.0% | 0.03% | +222.2% |
| Q2 2017 | $908,000 | -25.7% | 11,400 | -33.7% | 0.01% | -35.7% |
| Q1 2017 | $1,222,000 | +4600.0% | 17,200 | +3340.0% | 0.01% | – |
| Q4 2016 | $26,000 | -91.0% | 500 | -92.1% | 0.00% | -100.0% |
| Q3 2016 | $290,000 | +9566.7% | 6,300 | +6200.0% | 0.00% | – |
| Q2 2016 | $3,000 | -70.0% | 100 | -66.7% | 0.00% | – |
| Q1 2016 | $10,000 | +66.7% | 300 | +200.0% | 0.00% | – |
| Q4 2015 | $6,000 | +50.0% | 100 | 0.0% | 0.00% | – |
| Q3 2015 | $4,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BOOTHBAY FUND MANAGEMENT, LLC | 76 | $657,000 | 0.02% |
| GROUP ONE TRADING, L.P. | 66,700 | $5,770,000 | 0.01% |
| SIMPLEX TRADING, LLC | 275 | $2,379,000 | 0.00% |
| IMC-Chicago, LLC | 15,200 | $1,315,000 | 0.00% |
| JPMORGAN CHASE & CO | 44,200 | $3,824,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |